Entering text into the input field will update the search result below

Nu Skin reports Record 1st quarter and record Month.

May 04, 2011 3:37 PM ETNUS
Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

The First quarter earnings call just ended, bold emphasis is mine

Nu Skin Enterprises Reports Record First-Quarter Revenue and Raises Annual Guidance
PR Newswire Wednesday May 4, 2011, 7:30 am EDT

PROVO, Utah, May 4, 2011 /PRNewswire/ -- Nu Skin Enterprises, Inc. (NYSE: NUS)
today announced record first-quarter revenue of $395.8 million, a 9 percent
improvement over the prior year. Revenue for the quarter was positively impacted
5 percent by foreign currency fluctuations. Earnings per share for the quarter were
. Excluding non-cash charges of $32.8 million associated with a recent Japan
customs ruling, earnings per share were $0.56. This compares to earnings per share
in the prior-year period of $0.48.  

"Our solid first-quarter performance was driven by growth in our distributor force,
our dynamic product portfolio, strength in emerging markets, and a continued focus
on profitability and shareholder value," said Truman Hunt, president and CEO. "We
continue to lap quarters from the prior year that included large revenue increases
associated with the launch of ageLOC products in various regions. Posting growth
against large comparable quarters is particularly encouraging. In fact, we had our
largest revenue month in company history in March.

Live with Intention,

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.